Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT03707691
Recruiting Not applicable

Pitch Perception and Memory: Deficits and Training

NCT03707691 · tracked via the Priya Life Science France tracker
Sponsor
Hospices Civils de Lyon
Phase
Not applicable
Started
2019-11-26
Last updated
2026-10-22

Condition(s) studied

Cochlear Implants

Investigational drug(s) / intervention(s)

Listening tests. Pitch training protocolvisuo-spatial training protocolEEG/MEG/MRI recordings.

Listening tests. Pitch training protocol: The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.

visuo-spatial training protocol: The two training protocols consists of perceptual tasks (auditory or visual exercises) performed repetitively using a tablet. Each protocol consists in 30 sessions of \~20 minutes performed at home over a period of 15 weeks.

EEG/MEG/MRI recordings.: Listening tests. EEG/MEG/MRI recordings

Study summary

Pitch perception and memory are central in auditory cognition, in particular for sound source segregation and recognition, speech prosody and music processing. Here the investigator assess pitch perception and memory in hearing-impaired listeners wearing cochlear implant(s) and listeners with congenital amusia, both compared with control listeners. Behavioral, EEG, and MEG measures are collected in audio and audio-visual contexts to characterize pitch processing deficits, and test a pitch training program.

Eligibility

Sex
ALL
Min age
5 Years
Max age
90 Years
Healthy volunteers
Accepted
Inclusion Criteria: For adult participants: * Aged between 18 and 90 * Absence of neurological and psychiatric disorders * No major cognitive deficit, ability to understand and apply study instructions * Motivation to participate efficiently in the study * Written informed consent to participant in the study * Affiliated to social security * Control participants and participants with congenital amusia for Experiment 5: MRI/MEG compatibility For underage participants: * Subject aged 5 years and over * Informed consent of parents or guardians for the participation of the child being studied * No neurological or psychiatric history * Without major cognitive impairment and ability to understand and apply setpoint. * Subject affiliated to a social security scheme * Motivation to participate effectively in the project Exclusion Criteria: For adult participants: * Age below 18 or above 90 * Pregnant or breast-feeding woman For underage participants: \- Pregnant or nursing minors

Primary outcome measure(s)

  • percentages of correct responses in listening tests — during procedure
  • reaction times in listening tests — during procedure
  • Event-Related Fields — during procedure
    MEG measurements
  • Oscillations — during procedure
    MEG measurements

Trial sites (1)

FacilityCityRegionStatus
Lyon Neuroscience Research Center Bron France Recruiting

More Hospices Civils de Lyon trials in France

Cohort Study on the Use of the BOUGIE CAP™ Device for the Treatment of Benign and Short Esophageal Strictures Recruiting
Medico-economic Analysis of Clinical Pharmacy Activities Active, not recruiting
Capillary Refill Time Variation to Predict Oxygen Comsumption Variation After FLuid Challenge (CARTOFL) Starting soon
Pregnancy in Women With Rare Multisystemic Vascular Diseases: COGRare5 Study Recruiting
TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation Recruiting

Other trials for the same condition

The Value Electrical Stapedial Reflex Thresholds (eSRTs) Cochlear Implant Mapping Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03707691 on ClinicalTrials.gov ↗ ← All trials in France